High Visceral Fat is Associated with a Worse Survival after Liver Resection for Intrahepatic Cholangiocarcinoma

References

• Witjes CDM, KarimKos HE, Visser O, de Vries E, IJzermans JNM, de Man RA, Coebergh JWW, Verhoef C. Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival. HPB (Oxford). 2012;14(11):777–81. doi:10.1111/j.1477-2574.2012.00536.x.
   PubMed Web of Science ®Google Scholar
• Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33(6):1353–7. doi:10.1053/jhep.2001.25087.
   PubMed Web of Science ®Google Scholar
• Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: Systematic review and meta-analysis. JAMA Surg. 2014;149(6):565–74. doi:10.1001/jamasurg.2013.5137.
   PubMed Web of Science ®Google Scholar
• Blechacz B. Cholangiocarcinoma: Current knowledge and new developments. Gut Liver. 2017;11(1):13–26. doi:10.5009/gnl15568.
   PubMed Web of Science ®Google Scholar
• Sulpice L, Rayar M, Boucher E, Pracht M, Meunier B, Boudjema K. Treatment of recurrent intrahepatic cholangiocarcinoma. Br J Surg. 2012;99(12):1711–7. doi:10.1002/bjs.8953.
   PubMed Web of Science ®Google Scholar
• de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, et al. Intrahepatic cholangiocarcinoma: An international multi-institutional analysis of prognostic factors and lymph node assessment. JCO. 2011;29(23):3140–5. doi:10.1200/JCO.2011.35.6519
   PubMed Web of Science ®Google Scholar
• Okumura S, Kaido T, Hamaguchi Y, Kobayashi A, Shirai H, Fujimoto Y, Iida T, Yagi S, Taura K, Hatano E, et al. Impact of skeletal muscle mass, muscle quality, and visceral adiposity on outcomes following resection of intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2017;24(4):1037–45. doi:10.1245/s10434-016-5668-3
   PubMed Web of Science ®Google Scholar
• Zhou G, Bao H, Zeng Q, Hu W, Zhang Q. Sarcopenia as a prognostic factor in hepatolithiasis-associated intrahepatic cholangiocarcinoma patients following hepatectomy: a retrospective study. Int J Clin Exp Med. 2015;8(10):18245.
   PubMed Web of Science ®Google Scholar
• Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, Salloum C, Luciani A, Azoulay D. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg. 2015;261(6):1173–83. doi:10.1097/SLA.0000000000000743.
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, Nakagomi R, Kondo M, Nakatsuka T, Minami T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63(1):131–40. doi:10.1016/j.jhep.2015.02.031
   PubMed Web of Science ®Google Scholar
• van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TCK, IJzermans JNM. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99(4):550–7. doi:10.1002/bjs.7823
   PubMed Web of Science ®Google Scholar
• Cornet M, Lim C, Salloum C, Lazzati A, Compagnon P, Pascal G, Azoulay D. Prognostic value of sarcopenia in liver surgery. J Visc Surg. 2015;152(5):297–304. doi:10.1016/j.jviscsurg.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Okamura A, Watanabe M, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S. Implication of visceral obesity in patients with esophageal squamous cell carcinoma. Langenbeck’s Archiv Surg. 2018;403(2):245–53. doi:10.1007/s00423-017-1643-0
   PubMed Web of Science ®Google Scholar
• Clark W, Siegel EM, Chen YA, Zhao X, Parsons CM, Hernandez JM, Weber J, Thareja S, Choi J, Shibata D. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation. J Am Coll Surg. 2013;216(6):1070–81. doi:10.1016/j.jamcollsurg.2013.01.007.
   PubMed Web of Science ®Google Scholar
• Grignol VP, Smith AD, Shlapak D, Zhang X, Del Campo SM, Carson WE. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy. Surg Oncol. 2015;24(4):353–8. doi:10.1016/j.suronc.2015.09.002.
   PubMed Web of Science ®Google Scholar
• Mauland KK, Eng Ø, Ytre-Hauge S, Tangen IL, Berg A, Salvesen HB, Salvesen ØO, Krakstad C, Trovik J, Hoivik EA, et al. High visceral fat percentage is associated with poor outcome in endometrial cancer. Oncotarget. 2017;8(62):105184–95. doi:10.18632/oncotarget.21917
   PubMedGoogle Scholar
• Iwase T, Sangai T, Nagashima T, Sakakibara M, Sakakibara J, Hayama S, Ishigami E, Masuda T, Miyazaki M. Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients. Cancer Med. 2016;5(1):41–8. doi:10.1002/cam4.571
   PubMed Web of Science ®Google Scholar
• Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. The Lancet Oncol. 2008;9(7):629–35. doi:10.1016/S1470-2045(08)70153-0
   PubMed Web of Science ®Google Scholar
• Feng J, Liang B, Zhang H-Y, Liu Z, Jiang K, Zhao X-Q. Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients. WJGS. 2022;14(5):442–51. doi:10.4240/wjgs.v14.i5.442
   Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–5. doi:10.1038/nmeth.2089
   PubMed Web of Science ®Google Scholar
• Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211(1):283–6. doi:10.1148/radiology.211.1.r99ap15283.
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–13. doi:10.1097/01.sla.0000133083.54934.ae
   PubMed Web of Science ®Google Scholar
• Dai Z, Xu Y-C, Niu L. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2007;13(31):4199–206. doi:10.3748/wjg.v13.i31.4199
   PubMed Web of Science ®Google Scholar
• Nault J-C, Pigneur F, Nelson AC, Costentin C, Tselikas L, Katsahian S, Diao G, Laurent A, Mallat A, Duvoux C, et al. Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors. Dig Liver Dis. 2015;47(10):869–76. doi:10.1016/j.dld.2015.07.001.
   PubMedGoogle Scholar
• Chakedis J, Spolverato G, Beal EW, Woelfel I, Bagante F, Merath K, Sun SH, Chafitz A, Galo J, Dillhoff M, et al. Pre-operative Sarcopenia identifies patients at risk for poor survival after resection of biliary tract cancers. J Gastrointest Surg. 2018;22(10):1697–708. doi:10.1007/s11605-018-3802-1.
   PubMed Web of Science ®Google Scholar
• Imai K, Takai K, Maeda T, Watanabe S, Hanai T, Suetsugu A, Shiraki M, Shimizu M. Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment. Oncotarget. 2018;9(18):14058. doi:10.18632/oncotarget.24500 http://www.oncotarget.com/fulltext/24500
   PubMedGoogle Scholar
• Schlesinger S, Aleksandrova K, Pischon T, Fedirko V, Jenab M, Trepo E, Boffetta P, Dahm CC, Overvad K, Tjønneland A, et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer. 2013;132(3):645–57. doi:10.1002/ijc.27645
   PubMed Web of Science ®Google Scholar
• Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, et al. Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma. Liver Cancer. 2019;8(2):92–109. doi:10.1159/000488779
   PubMed Web of Science ®Google Scholar
• Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, Ferlay J, Valery PC, Bray F, McGlynn KA. International trends in hepatocellular carcinoma incidence, 1978–2012. Int J Cancer. 2020;147(2):317–30. http://onlinelibrary.wiley.com/ doi:10.1002/ijc.32723
   PubMed Web of Science ®Google Scholar
• Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. JCO. 2013;31(12):1539–47. doi:10.1200/JCO.2012.45.2722
   PubMed Web of Science ®Google Scholar
• Ebadi M, Martin L, Ghosh S, Field CJ, Lehner R, Baracos VE, Mazurak VC. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br J Cancer. 2017;117(1):148–55. doi:10.1038/bjc.2017.149
   PubMed Web of Science ®Google Scholar
• McGown C, Birerdinc A, Younossi ZM. Adipose tissue as an endocrine organ. Clin Liver Dis. 2014;18(1):41–58. doi:10.1016/j.cld.2013.09.012.
   PubMed Web of Science ®Google Scholar
• Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11(1):11–8. doi:10.1111/j.1467-789X.2009.00623.x.
   PubMed Web of Science ®Google Scholar
• Freese KE, Kokai L, Edwards RP, Philips BJ, Sheikh MA, Kelley J, Comerci J, Marra KG, Rubin JP, Linkov F. Adipose-derived stems cells and their role in human cancer development, growth, progression, and metastasis: a systematic review. Cancer Res. 2015;75(7):1161–8. doi:10.1158/0008-5472.CAN-14-2744.
   PubMed Web of Science ®Google Scholar
• Ong WK, Tan CS, Chan KL, Goesantoso GG, Chan XHD, Chan E, Yin J, Yeo CR, Khoo CM, So JBY, et al. Identification of specific cell-surface markers of adipose-derived stem cells from subcutaneous and visceral fat depots. Stem Cell Reports. 2014;2(2):171–9. doi:10.1016/j.stemcr.2014.01.002.
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, de Courten MPJ, Stojanovska L, Blatch GL, Tangalakis K, de Courten B. The complex immunological and inflammatory network of adipose tissue in obesity. Mol Nutr Food Res. 2016;60(1):43–57. doi:10.1002/mnfr.201500272.
   PubMed Web of Science ®Google Scholar
• Florio AA, Campbell PT, Zhang X, Zeleniuch-Jacquotte A, Wactawski-Wende J, Smith-Warner SA, Sinha R, Simon TG, Sesso HD, Schairer C, et al. Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project. Int J Cancer. 2020;147(3):675–85. doi:10.1002/ijc.32760
   PubMed Web of Science ®Google Scholar
• Joglekar S, Asghar A, Mott SL, Johnson BE, Button AM, Clark E, Mezhir JJ. Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol. 2015;111(6):771–5. doi:10.1002/jso.23862.
   PubMed Web of Science ®Google Scholar
• Okumura S, Kaido T, Hamaguchi Y, Fujimoto Y, Masui T, Mizumoto M, Hammad A, Mori A, Takaori K, Uemoto S. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery. 2015;157(6):1088–98. doi:10.1016/j.surg.2015.02.002
   PubMed Web of Science ®Google Scholar
• Lodewick TM, van Nijnatten TJA, van Dam RM, van Mierlo K, Dello SAWG, Neumann UP, Olde Damink SWM, Dejong CHC. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB. 2015;17(5):438–46. doi:10.1111/hpb.12373
   PubMed Web of Science ®Google Scholar
• Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng J, Edil BH, Wolfgang CL, Schulick RD, Choti MA, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford). 2011;13(7):439–46. doi:10.1111/j.1477-2574.2011.00301.x.
   PubMed Web of Science ®Google Scholar
• Harimoto N, Shirabe K, Yamashita Y-I, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y, Nishie A, Yamanaka T. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma: Sarcopenia and outcome of hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100(11):1523–30. doi:10.1002/bjs.9258.
   PubMed Web of Science ®Google Scholar
• Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg. 2014;149(5):432–8. doi:10.1001/jamasurg.2013.5168
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, Wan X, Liu G, Wu D, Shi L, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. JCO. 2013;31(9):1188–95. doi:10.1200/JCO.2012.41.5984
   PubMed Web of Science ®Google Scholar
• Pan D, Wang S, Su M, Wei J, Wang K, Luo P, Smith JD, Ma G, Sun G. Roles of drinking and diet in the U-shaped relationship between smoking and BMI in middle-aged and elderly Chinese rural adults. Sci Rep. 2020;10(1):17118. doi:10.1038/s41598-020-74414-0
   PubMed Web of Science ®Google Scholar